Kv1.7

1

Ye F et al. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
Toxins (Basel), 2016 , 8 ().

2

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

3

Carrisoza-Gaytán R et al. Differential expression of the Kv1 voltage-gated potassium channel family in the rat nephron.
J. Mol. Histol., 2014 Oct , 45 (583-97).

4

Qu YH et al. Remodeling of ion channel expression may contribute to electrophysiological consequences caused by methamphetamine in vitro and in vivo.
Biochem. Biophys. Res. Commun., 2014 Jan 10 , 443 (441-6).

5

Firth AL et al. Functional ion channels in human pulmonary artery smooth muscle cells: Voltage-dependent cation channels.
Pulm Circ, 2011 Jan 1 , 1 (48-71).

6

Chen P et al. Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxins.
J. Biol. Chem., 2010 May 14 , 285 (14882-9).

7

Rangaraju S et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23.
J. Biol. Chem., 2010 Mar 19 , 285 (9124-36).

8

Zhu J et al. The Kv1.2 potassium channel: the position of an N-glycan on the extracellular linkers affects its protein expression and function.
Brain Res., 2009 Jan 28 , 1251 (16-29).

9

Shoudai K et al. Effects of various K+ channel blockers on spontaneous glycine release at rat spinal neurons.
Brain Res., 2007 Jul 9 , 1157 (11-22).

10

Hoegg S et al. Phylogenomic analyses of KCNA gene clusters in vertebrates: why do gene clusters stay intact?
BMC Evol. Biol., 2007 , 7 (139).

11

García-Villegas R et al. Potassium channels lost during harvesting of epithelial cells are restored with a kinetics that depends on channel species.
Cell. Physiol. Biochem., 2007 , 20 (405-16).

12

Fantozzi I et al. Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells.
Am. J. Physiol. Lung Cell Mol. Physiol., 2006 Nov , 291 (L993-1004).

13

Finol-Urdaneta RK et al. Molecular and Functional Differences between Heart mKv1.7 Channel Isoforms.
J. Gen. Physiol., 2006 Jul , 128 (133-45).

14

Ordög B et al. Gene expression profiling of human cardiac potassium and sodium channels.
Int. J. Cardiol., 2006 Aug 28 , 111 (386-93).

15

Barfield JP et al. Characterization of potassium channels involved in volume regulation of human spermatozoa.
Mol. Hum. Reprod., 2005 Dec , 11 (891-7).

16

Vennekamp J et al. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Mol. Pharmacol., 2004 Jun , 65 (1364-74).

17

Bardien-Kruger S et al. Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI).
Eur. J. Hum. Genet., 2002 Jan , 10 (36-43).

18

Kashuba VI et al. Initial isolation and analysis of the human Kv1.7 (KCNA7) gene, a member of the voltage-gated potassium channel gene family.
Gene, 2001 May 2 , 268 (115-22).

19

Davies AR et al. Kv channel subunit expression in rat pulmonary arteries.
Lung, 2001 , 179 (147-61).

20

Kálmán K et al. Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7.
J. Biol. Chem., 1998 Mar 6 , 273 (5851-7).